Myriad Genetics, Inc. (MYGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 10:36AM EST. Market open.
| Previous Close | 20.37 |
| Open | 20.01 |
| Bid | 19.66 x 900 |
| Ask | 19.69 x 800 |
| Day's Range | 19.52 - 20.01 |
| 52 Week Range | 13.92 - 28.18 |
| Volume | |
| Avg. Volume | 764,852 |
| Market Cap | 1.583B |
| Beta (5Y Monthly) | 1.76 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Myriad Genetics (MYGN) Ailed by Mounting Costs, FX Headwind
Myriad Genetics' (MYGN) significant gross margin contraction and operating loss as a result of mounting cost pressure are concerning.
- Simply Wall St.
Further weakness as Myriad Genetics (NASDAQ:MYGN) drops 5.5% this week, taking five-year losses to 51%
Statistically speaking, long term investing is a profitable endeavour. But along the way some stocks are going to...
- Zacks
Halozyme Therapeutics (HALO) Up 16.2% Since Last Earnings Report: Can It Continue?
Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2023 Yahoo. All rights reserved.
